Nghiên cứu mới về vaccine COVID-19 từ ngày 14/1 đến ngày 21/1/2022

Cục Thông tin KH&CN Quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về vaccine COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 14/1 đến ngày 21/1/2022. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài. 


1. Side effects of messenger RNA vaccines and prior history of COVID-19, a cross-sectional study

American Journal of Infection Control, 28 October 2021, Volume 50, Issue 1 (Cover date: January 2022), Pages 8-14

Renuka Ananth Kalyan Kadali, Ravali Janagama, Isha Shah

2. Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models
EBioMedicine, 21 December 2021, Volume 75 (Cover date: January 2022), Article 103762

Runhong Zhou, Pui Wang, Zhiwei Chen

3. Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data
Multiple Sclerosis and Related Disorders, 2 December 2021, Volume 57 (Cover date: January 2022), Article 103433

Samantha Epstein, Zongqi Xia, Sarah F. Wesley

4. Novel nanostructure-coupled biosensor platform for one-step high-throughput quantification of serum neutralizing antibody after COVID-19 vaccination
Biosensors and Bioelectronics, 8 December 2021, Volume 199 (Cover date: 1 March 2022), Article 113868

Liping Huang, Ying Li, Gang L. Liu

5. BCG vaccination and the risk of COVID 19: A possible correlation

Virology, 28 October 2021, Volume 565 (Cover date: 2 January 2022), Pages 73-81

Sara M. Ahmed, Mohamed A. Nasr, Nagwa El-Badri

6. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?

Placenta, 6 December 2021, Volume 117 (Cover date: January 2022), Pages 161-168

Sudha Warrier, S Mohana Sundaram, Ananthakrishnan

7. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study

The Lancet Infectious Diseases, 1 September 2021, Volume 22, Issue 1 (Cover date: January 2022), Pages 43-55

Michela Antonelli, Rose S Penfold, Claire J Steves

8. Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273
Journal of Virological Methods, 23 September 2021, Volume 299 (Cover date: January 2022), Article 114297

Alexander Krüttgen, Maike Lauen, Michael Kleines

9. Genome sequencing of SARS-CoV-2 reveals the prevalence of variant B 1.1.7 in Egypt
Infection, Genetics and Evolution, 17 December 2021, Volume 97 (Cover date: January 2022), Article 105191

Mohamed G. Seadawy, Ahmed F. Gad, Mervat G. Hassan

10. Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers
Journal of Infection and Public Health, 24 December 2021, Volume 15, Issue 2 (Cover date: February 2022), Pages 182-186

Pragya D. Yadav, Prasad Sarkale, Sreelekshmy Mohandas

11. A peptide-based assay discriminates individual antibody response to SARS-CoV-2
Genes & Diseases, 5 February 2021, Volume 9, Issue 1 (Cover date: January 2022), Pages 275-281

Immacolata Polvere, Serena Voccola, Tiziana Zotti

12. Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19

Journal of Immunological Methods, 8 November 2021, Volume 500 (Cover date: January 2022), Article 113182

Luciana Villafañe, Lucía Gallo Vaulet, Fabiana Bigi

13. Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations

Infection, Genetics and Evolution, 18 November 2021, Volume 97 (Cover date: January 2022), Article 105153

William M. Showers, Sonia M. Leach, Michael Strong

14. Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial

International Journal of Infectious Diseases, 22 October 2021, Volume 114 (Cover date: January 2022), Pages 165-174

Michiko Asano, Hiroshi Okada, Johan Vekemans


1. Anti-SARS-CoV-2 spike protein and neutralizing antibodies at one and 3 months after 3 doses of SARS-CoV-2 vaccine in a large cohort of solid-organ-transplant patients

Nassim Kamar, Florence Abravanel, Olivier Marion, Laure Esposito, Anne Laure Hebral, Chloé Médrano, Joelle Guitard, Laurence Lavayssière, Olivier Cointault, Marie Bétriace Nogier, Julie Bellière, Stanislas Faguer, Chloé Couat, Arnaud Del Bello, Jacques Izopet

American Journal of TransplantationAccepted Articles

First published: 09 January 2022


Maria Nikolova, Yana Todorova, Radoslava Emilova, Iva Trifonova, Teodora Gladnishka, Nina Petrova-Yancheva, Tatyana Chervenyakova, Elena Dragusheva, Georgi Popov, Iva Christova

Journal of Medical VirologyAccepted Articles

First published: 07 January 2022

3. Managing the risk of COVID-19 via vaccine passports: Modeling economic and policy implications

Rajeev K. Goel, James R. Jones

Managerial and Decision EconomicsEarly View

First published: 09 January 2022

4. Attitudes Towards Influenza and Pneumococcal Vaccines in Parents of Asthmatic Children During the COVID-19 Pandemic

Murat Özer, Nevzat Başkaya, İlknur Bostancı

Pediatric PulmonologyAccepted Articles

First published: 08 January 2022

5. Global sharing of COVID-19 vaccines: A duty of justice, not charity

Nancy S. Jecker

Developing World BioethicsEarly View

First published: 08 January 2022


1. Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan.

Saita M, Yan Y, Ito K, Sasano H, Seyama K, Naito T.J Infect Chemother. 2022 Jan;28(1):116-119. doi: 10.1016/j.jiac.2021.09.009. Epub 2021 Sep 16.

2. Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study.

Rottenstreich M, Sela HY, Rotem R, Kadish E, Wiener-Well Y, Grisaru-Granovsky S.BJOG. 2022 Jan;129(2):248-255. doi: 10.1111/1471-0528.16941. Epub 2021 Oct 6.

3. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study.

McMahon DE, Kovarik CL, Damsky W, Rosenbach M, Lipoff JB, Tyagi A, Chamberlin G, Fathy R, Nazarian RM, Desai SR, Lim HW, Thiers BH, Hruza GJ, French LE, Blumenthal K, Fox LP, Freeman EE.J Am Acad Dermatol. 2022 Jan;86(1):113-121. doi: 10.1016/j.jaad.2021.09.002. Epub 2021 Sep 10.

4. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.

Sauré D, O'Ryan M, Torres JP, Zuniga M, Santelices E, Basso LJ.Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.

5. COVID-19 Vaccination Associated With Reduced Postoperative SARS-CoV-2 Infection and Morbidity.

Prasad NK, Lake R, Englum BR, Turner DJ, Siddiqui T, Mayorga-Carlin M, Sorkin JD, Lal BK.Ann Surg. 2022 Jan 1;275(1):31-36. doi: 10.1097/SLA.0000000000005176.

6. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.

Wan EYF, Chui CSL, Lai FTT, Chan EWY, Li X, Yan VKC, Gao L, Yu Q, Lam ICH, Chun RKC, Cowling BJ, Fong WC, Lau AYL, Mok VCT, Chan FLF, Lee CK, Chan LST, Lo D, Lau KK, Hung IFN, Leung GM, Wong ICK.Lancet Infect Dis. 2022 Jan;22(1):64-72. doi: 10.1016/S1473-3099(21)00451-5. Epub 2021 Aug 16.

7. Parsonage-Turner Syndrome Following COVID-19 Vaccination: MR Neurography.

Queler SC, Towbin AJ, Milani C, Whang J, Sneag DB.Radiology. 2022 Jan;302(1):84-87. doi: 10.1148/radiol.2021211374. Epub 2021 Aug 17.

8. Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.

Hunjan MK, Roberts C, Karim S, Hague J.Clin Exp Dermatol. 2022 Jan;47(1):188-190. doi: 10.1111/ced.14878. Epub 2021 Sep 24.


1. Association of vitamin D status with COVID-19 and its severity

Jae Hyun Bae, Hun Jee Choe… in Reviews in Endocrine and Metabolic Disorde… (2022)

2. No substantial excess all-cause mortality among cardiac implantable electronic device patients during the first COVID‑19 lockdown in the Leiden area

M. Feijen, A. D. Egorova, E. T. van der Velde, M. J. Schalij… in Netherlands Heart Journal (2022)

3. Epidemiological Control of COVID-19 Through the Theory of Variable Structure and Sliding Mode Systems

Débora Marques Lopes Santos… in Journal of Control, Automation and Electri… (2022)

4. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms

Xuhuan Tang, Fang Zheng in Neurological Sciences (2022)

5. COVID-19: a look into the modern age pandemic

Mohammad Aadil Qamar in Journal of Public Health (2022)

Các công bố về COVID-19 trước thời gian trên:

Cập nhật các công bố về COVID-19 từ ngày 7/1 đến ngày 14/1/2022

Cập nhật các công bố về COVID-19 từ ngày 1/1 đến ngày 7/1/2022

Nguồn: Cục Thông tin KH&CN Quốc gia, 21/1/2021